Medicine How Colorado’s trying to lower health care costs
If there’s an idea that might reduce health care costs, there’s a good chance Colorado’s trying it out.
The state’s
Other than the importation plan, which has to be approved by the
“I think the state is trying to see which of these two approaches will get better results,” he said.
Gov.
“America does health care poorly,” he said. “We want good ideas from the left, the right, the middle.”
Unlike a full public option for health coverage, Colorado Option plans are run by insurance companies. The difference from other plans is that they’re standardized, meaning that all option plans have similar out-of-pocket costs; they offer more services without co-pays or other direct costs; and they’re required to reduce premiums by 15% over the next three years, adjusted for inflation.
Not all Colorado Option plans met the 5% reduction for 2023, though the majority of people who get their insurance through the marketplace have access to at least one plan that did, according to the
About 35,000 people enrolled in Colorado Option plans this year, including about 10,000 who weren’t eligible for tax credits because of their immigration status, but received state subsidies.
The 25,000 who are citizens and could choose any plan represent about 13% of people buying on the individual market in
“A new product taking over 13% of the market is going to be eye-popping,” he said.
Also, it can be worthwhile to offer patients a health insurance option with fewer out-of-pocket costs and more incentives for primary care, he said. Customers don’t have to pay for visits to their primary care or mental health provider, or for diabetes testing supplies.
“While they are not the lowest-cost plans, they are the highest-value plans,” he said.
Reinsurance
Reinsurance is one of the bigger success stories in efforts to bring costs down, even if people don’t often think about it, Fox said. And since the state has long-term funding for it, the benefits will continue for at least the next few years, he said.
“Colorado, or at least some parts of our state, were some of the most expensive (insurance) markets in the country,” he said. “That’s no longer the case because of reinsurance.”
It’s essentially a backstop, limiting how much insurance companies selling on the marketplace have to pay out if a customer’s care exceeds
Insurance companies are required to spend 80% of the premiums they collect on customers’ care, so if the amount they’re on the hook for goes down, so do premiums. That decrease has been largely overridden by other increased costs, meaning reinsurance has been more of a method to limit rate hikes than to bring rates down.
Connect for Health Colorado estimated premiums for 2023 would have been about 20% higher without reinsurance.
Purchasing alliance
The state employee health plan and other partners in the
Ultimately, health care costs aren’t a problem the state can solve alone, since about half of Coloradans work for employers who aren’t based here, Smith said. Right now, the purchasing alliance is working with national employers to set quality standards — say, the percentage of patients with diabetes whose blood sugar should be under control — which local doctors can meet however they deem best, he said.
“How you improve, where there’s room to improve, is very local,” he said.
Drug importation
If the FDA approves the importation of drugs, participating residents could save up to 65% on certain common medications, for a total savings of
The FDA still hasn’t approved similar proposals from
FDA Commissioner Dr.
“Florida got a little ahead of their skis,” she said. “That’s OK. We learned from Florida.”
Drug affordability board
The prescription drug affordability board is still finalizing its rules, and is expected to start reviewing drugs in March.
The board will be limited to setting maximum prices for 12 drugs a year, for three years. Members of the public can ask the board to review certain drugs, and a review is triggered if a drug’s price increases 10% within one year; a brand-name drug costs more than
How effective the board is will depend on how aggressively it sets its maximum prices; how many people take the drugs it is regulating; and whether there are any unintended consequences, such as drugmakers refusing to sell in
Price transparency
In June, Polis signed a bill prohibiting hospitals that haven’t posted their prices from suing patients or sending them to collections over unpaid medical bills. The state doesn’t enforce the law, however; patients who believe a hospital pursued aggressive tactics improperly have to sue to get their debt forgiven and collect damages.
No one tracks these cases, so it’s not clear if anyone has sued, and if so, if they were successful. It’s possible that the chance of a lawsuit could discourage hospitals from sending patients to collections, or encourage more transparency in posting prices.
The
Transparency can be helpful for people who are scheduling care, but it doesn’t do much for those who have a medical emergency, Fox said.
Discounted hospital care law
No one is tracking how many people received large bills before and after the law took effect, but Fox said that fewer people have been calling the Colorado Consumer Health Initiative asking for help in the months since.
“We’re already seeing some benefits from our consumer assistance program,” he said.
Insulin price cap
No one tracks how many people have taken advantage of the cap or how much they’ve saved. But people with diabetes have reported they have an easier time affording their insulin, Lt. Gov.
“Behind every number, there’s a person,” she said.
More to come?
Some laws targeting health costs that passed last year won’t take effect until 2024. One of those is House Bill 1370, which will require insurance companies to pass drug rebates they receive onto customers.
A bill currently in the legislature would build on Colorado’s law capping out-of-pocket costs for insulin, placing a similar cap on EpiPens, which treat life-threatening allergic reactions.
Polis said he doesn’t anticipate the state will continue addressing the price of single drugs indefinitely, but EpiPens and insulin are special cases.
“These are cheap to manufacture. They’ve been around for decades,” he said. “That’s different from a brand-new drug that cost a billion to develop.”
In his State of the State address, Polis called for legislative changes to ensure nonprofit hospitals aren’t charging prices he considers excessive. The
“In exchange for (not paying taxes), they should carry the responsibility of not overcharging patients,” Polis said in an interview, adding that insurance companies could be an ally if the state can put the “fire in their belly.”
Some efforts, like the reinsurance program, have stabilized the cost of health insurance in the state, Fox said. It remains to be seen if the newer laws can actually reduce costs for individuals and for the state as a whole, he said.
“Each of these measures that we’ve put forward in
Fitzgerald named to two House financial services subcommittees
Fitzgerald named to two subcommittees on House Financial Services Committee
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News